🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Spain
Clinical trial register · Spain

Studies with a Spanish investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5885 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
5885
Studies in scope
all four open statuses
3103
Recruiting now
open to new participants
1139
Lead sponsors
across recruiting studies
Top sites
Barcelona 3233 Madrid 3015 Valencia 1201 Seville 1055 Málaga 741
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca221 Novartis Pharmaceuticals152 Merck Sharp & Dohme LLC133 Janssen Research & Development, LLC124 Hoffmann-La Roche124
Site location
Barcelona3233 Madrid3015 Valencia1201 Seville1055 Málaga741
All 455 locations
Target enrolment
to

Trials in this register

5885 of 5885 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Home-based Graded Repetitive Arm Supplementary Program for Quality of Life and Functional Upper Limb Recovery
NCT07146789Stroke With Hemiparesis
Universidad Miguel Hernandez de Elche
Not applicable
70
Valencia
2025-04-01
Not yet open
Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether
NCT06846294Diet Intervention, Physical Activity Intervention, Standard Care Control
University of Exeter
Not applicable
90
Madrid
2025-04-01
Recruiting
Protocol to Improve the Representation of the Reproductive Process in Spanish Fiction.
NCT06842004Sexual Health, Community Participation, Social Norms
Universitat de Lleida
Not applicable
60
Lleida
2025-04-01
Not yet open
Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.
NCT06746376Arthralgia
Universidad Europea de Madrid
Not applicable
32
Villaviciosa de Odón
2025-04-01
Recruiting
Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy
NCT07400237Cholecystectomy
Consorci Sanitari Integral
Not applicable
62
Sant Joan Despí
2025-04-01
Recruiting
Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions
NCT07422090Suicide Attempt
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Observational
5,000
Madrid
2025-04-01
Recruiting
DigiDiab Pilot: Impact Study Hospital
NCT06605872Type 2 Diabetes
Medical University of Graz
Observational
500
Tarragona
2025-04-01
Active, closed
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
NCT06864169Gastrointestinal Cancer
DrugsRaludotatug Deruxtecan·R-DXd
Merck Sharp & Dohme LLC
Phase 2
160
Badalona, Santander, Barcelona, Madrid
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Barcelona, Majadahonda, Pamplona, Málaga, Valencia
2025-04-01
Recruiting
Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)
NCT06852443Prevention, Well Being, Sexual Behavior, Behavior Change
Charite University, Berlin, Germany
Not applicable
180
Barcelona
2025-04-01
Recruiting
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
NCT06480955Bone Metastases
Cardiovascular and Interventional Radiological Society of Europe
Observational
50
Valencia
2025-04-01
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
NCT06873945Alopecia Areata
DrugsLitfulo·Ritlecitinib
Pfizer
Phase 3
674
Santiago de Compostela, Córdoba, Madrid, Zaragoza
2025-04-01
Active, closed
European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection
NCT06935487Prostate Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
806
Barcelona
2025-04-01
Not yet open
Oscillometry in the COPD Exacerbator Phenotype With Triple Inhaled Therapy Study
NCT06931899COPD (Chronic Obstructive Pulmonary Disease)
Hospital Universitari de Bellvitge
Observational
63
L'Hospitalet de Llobregat
2025-04
Not yet open
Effectiveness of Therapeutic Exercise Combined With Respiratory Muscle Training in Patients With Subacute Stroke
NCT06949839Stroke
Ana Lista Paz
Not applicable
64
A Coruña
2025-04
Not yet open
Effects of a Prehabilitation Program in Patients Undergoing Lumbar Radiculopathy Surgery
NCT06145620Lumbar Radiculopathy
Cardenal Herrera University
Not applicable
100
Valencia
2025-04
Not yet open
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733Leukemia, Plasma Cell
Fundacion Clinic per a la Recerca Biomédica
Phase 2
25
Santander, Madrid, Murcia, Pamplona, Salamanca, Barcelona
2025-04
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116Relapsed or Refractory B-cell Malignancies, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL)
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Phase 1
85
Madrid, Pamplona
2025-03-31
Recruiting
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
NCT06898450Advanced Solid Tumors Cancer, MSI-H Cancer
Nimbus Wadjet, Inc.
Phase 1/2
134
Barcelona, Madrid
2025-03-31
Not yet open
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT06919250Lupus Erythematosus, Systemic
University of Oviedo
Observational
63
Oviedo
2025-03-31
Recruiting
Footwear Difference in Sports Use in Runners With Functional Equinus
NCT06930287Sport Injury
Universidad Católica de Ávila
Observational
20
Salamanca
2025-03-31
Recruiting
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
NCT06731907Non-small Cell Lung Cancer
DrugsPatritumab deruxtecan·Nab-paclitaxel·Pemetrexed·Paclitaxel
Merck Sharp & Dohme LLC
Phase 2
90
L'Hospitalet de Llobregat, Barcelona, Madrid
2025-03-30
Recruiting
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
NCT06830759Diffuse Large B-cell Lymphoma, Follicular Lymphoma
AbbVie
Observational
700
A Coruña, Badalona, Sabadell, Córdoba, Marbella, Pamplona, Seville, Manises
2025-03-28
Recruiting
Effects of Education and Exercise on Pain, Psychosocial Factors, and Upper Limb Function in Non-specific Neck Pain.
NCT06889389Neck Pain, Patient Education, Exercise Therapy, Fear
Universidad Miguel Hernandez de Elche
Not applicable
81
Elche
2025-03-28
Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
NCT06750289Eosinophilic Asthma
AstraZeneca
Phase 3
400
Alcorcón, Alzira (Valencia), Badalona, Barakaldo, Barcelona, Burgos, Cáceres, Granada
2025-03-28
Recruiting
The Pivotal Study of RapidPulseTM Aspiration System
NCT06029491Acute Ischemic Stroke
RapidPulse, Inc
Not applicable
170
Alicante, Badalona, Barcelona, Girona, Madrid
2025-03-27
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598Carcinoma, Non-Small-Cell Lung
DrugsOlomorasib·Durvalumab·Pembrolizumab
Eli Lilly and Company
Phase 3
700
Badajoz, Barcelona, Hospitalet, Jerez de la Frontera, Las Palmas de Gran Canaria, Madrid, Málaga, Palma
2025-03-27
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
NCT06989112Endometrial Cancer
DrugsTaxotere·Rilvegostomig·Paraplatin·Taxol
AstraZeneca
Phase 3
600
A Coruña, Córdoba, Donostia / San Sebastian, El Palmar, L'Hospitalet de Llobregat, Madrid, Palma de Mallorca, Valencia
2025-03-27
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
NCT06795022Hepatocellular Carcinoma
AstraZeneca
Phase 1/2
304
Barcelona, Pamplona
2025-03-27
Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT06644781Esophageal Squamous Cell Carcinoma
DrugsIfinatamab Deruxtecan·Irinotecan·Docetaxel·Paclitaxel
Daiichi Sankyo
Phase 3
510
Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona
2025-03-27
Recruiting
Comparison of the Effectiveness of Classical Perineal Massage Therapy Versus the Use of an Intravaginal Device to Reduce Postpartum Perineal Pain
NCT06921174Pelvic Pain
Instituto Sexológico Murciano
Phase 2
140
Murcia
2025-03-27
Recruiting
Dietary Strategy to Tackle Cognitive and Locomotor Abilities in Early Elderly Subjects
NCT06871384Cognitive Disorders, Muscular Disorders, Atrophic
University Rovira i Virgili
Not applicable
72
Logroño, Reus
2025-03-26
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT06932263Asthma
DrugTozorakimab
AstraZeneca
Phase 2
540
Barcelona, Madrid, Málaga, Mérida, Patraix, Santander
2025-03-26
Recruiting
Desarda Tissue Technique vs Lichtenstein Technique for Primary Inguinal Hernia Repair
NCT06650878Inguinal Hernia Unilateral, Complications of Surgical Procedures or Medical Care
Consorci Sanitari de l'Alt Penedès i Garraf
Not applicable
478
Sant Pere de Ribes
2025-03-26
Recruiting
Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices
NCT07267104COPD (Chronic Obstructive Pulmonary Disease)
Corporacion Parc Tauli
Observational
75
Sabadell
2025-03-25
Recruiting
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
NCT06818643Advanced Solid Tumors, Malignant Neoplasm
DrugMK-3120
Merck Sharp & Dohme LLC
Phase 1/2
270
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga
2025-03-25
Recruiting
Keep On Keep Up Bladder Health: Co-creating and Testing a Self-management Technological Solution for Ageing Well
NCT06583733Urinary Incontinence in Old Age
University of Vic - Central University of Catalonia
Not applicable
120
Lleida, Vic
2025-03-24
Recruiting
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
NCT06368245Spinal Fusion
AO Foundation, AO Spine
Observational
1,244
Barcelona
2025-03-24
Recruiting
A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
NCT06672523Advanced Solid Tumors With Homozygous MTAP Deletion
DrugBMS-986504
Bristol-Myers Squibb
Phase 1
8
Logroño, Madrid
2025-03-24
Recruiting
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
NCT06651229Leukemia, Myeloid, Acute, Myelodysplastic Neoplasms
DrugsAzacitadine·Venetoclax
Janssen Research & Development, LLC
Phase 1
155
Madrid, Pamplona, Seville
2025-03-21
Recruiting
A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours
NCT06977737Solid Tumor, Adult
Accession Therapeutics Limited
Phase 1/2
72
Barcelona, Madrid, Rioja
2025-03-21
Recruiting
Study of the Effects of Time-Restricted Feeding on the Immune Function of Individuals With Obesity
NCT06858683Obesity and Obesity-related Medical Conditions
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
45
Barcelona
2025-03-21
Active, closed
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
NCT06726265Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
DrugsEfti·Pemetrexed·Paclitaxel·Cisplatin
Immutep S.A.S.
Phase 3
756
Badalona, Barcelona, Córdoba, Madrid, Málaga, Oviedo, Sabadell, Seville
2025-03-21
Recruiting
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
NCT06914128MTAP-deleted Solid Tumors
Bayer
Phase 1/2
450
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Málaga, Valencia, Pamplona
2025-03-21
Recruiting
Predictive Model for Mortality in Older People With Critical Illness
NCT06727903Critical Illness
Consorci Sanitari de l'Alt Penedès i Garraf
Observational
450
Badalona, Sant Pere de Ribes, Barcelona, Girona
2025-03-20
Recruiting
Fissios© and Postoperative Complications (FPoC Trial)
NCT06732193Surgical Procedure, Unspecified, Non Small Cell Lung Cancer, Surgery Scheduled, Thoracic Surgery
Carlos Alfredo Fraile Olivero, MD, PhD.
Not applicable
560
Madrid
2025-03-20
Recruiting
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
NCT06797635Breast Neoplasms, Breast Cancer
DrugsEpirubicin Hydrochloride·Patritumab deruxtecan·Doxorubicin Hydrochloride·Olaparib
Merck Sharp & Dohme LLC
Phase 2
372
Badalona, Madrid, Córdoba
2025-03-20
Active, closed
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
NCT06840392Hidradenitis Suppurativa
DrugsRemibrutinib A·Remibrutinib B
Novartis Pharmaceuticals
Phase 3
565
Granada, Palma, Barcelona, Granollers, Las Palmas GC, Madrid, Pontevedra, Seville
2025-03-20
Recruiting
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
NCT06788912Lung Neoplasm Malignant
DrugsSteroid mouthwash (dexamethasone·Acetaminophen·Sacituzumab tirumotecan·Pemetrexed
Merck Sharp & Dohme LLC
Phase 2
60
Barcelona
2025-03-20
Active, closed
A Study of Navenibart in Participants With Hereditary Angioedema
NCT06842823Hereditary Angioedema (HAE)
DrugNavenibart
Astria Therapeutics, Inc.
Phase 3
157
Barcelona, Madrid, Santa Cruz de Tenerife, Seville, Valencia
2025-03-20
Recruiting
Evaluation of the Nutritional Status of Omega-3 Fatty Acids and the Possible Influences of Dietary Patterns and Different Socioeconomic Factors, in a Spanish Population Over 60 Years of Age
NCT06916455Fatty Acids, Omega-3
Universidad de Granada
Observational
800
Granada
2025-03-19
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT06819007Ovarian Cancer
DrugsTrastuzumab deruxtecan·Bevacizumab
Daiichi Sankyo
Phase 3
582
A Coruña, Barcelona, Córdoba, El Palmar, Madrid, Palma, Pamplona, Planta Baja
2025-03-19
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07032662Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH
Phase 2
162
Barcelona, Bilbao, Córdoba, Santiago de Compostela, Valencia
2025-03-18
Active, closed
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T)
DrugN-Acetyl-L-Leucine
IntraBio Inc
Phase 3
60
Madrid
2025-03-18
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
NCT06376162Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia
DrugsZiftomenib·Cytarabine·Fludarabine
PedAL BCU, LLC
Phase 1
20
Barcelona, Madrid
2025-03-18
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305Chronic Obstructive Pulmonary Disease (COPD)
DrugTezepelumab
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Active, closed
A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT06799520Systemic Lupus Erythematosus (SLE), Alopecia Areata (AA), Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 1
30
Barcelona, Granada
2025-03-17
Recruiting
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878Moderately to Severely Active Crohns Disease
DrugAfimkibart
Hoffmann-La Roche
Phase 3
600
Santander, Galdacao, Madrid, Murcia, Valencia, Valladolid
2025-03-17
Recruiting
Promoting Safe Medication Practices in the Classroom
NCT07389538Self Medication
Universidad de Granada
Not applicable
202
Granada
2025-03-17
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354Triple Negative Breast Neoplasms
DrugsSacituzumab tirumotecan·Nab-paclitaxel·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
1,000
Seville, L'Hospitalet de Llobregat, Madrid, Valencia, Barcelona
2025-03-16
Active, closed
Opioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025)
NCT07771049Pain Management, Colorectal Surgery, Opioid Free Anesthesia, Postoperative Complications
DrugOpioid-Free Anesthesia
Hospital Universitario La Fe
Phase 1/2
200
Arrecife, Zaragoza
2025-03-15
Not yet open
Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
NCT06815328Stroke, Spasticity, Post-stroke, Muscle Hypertonia
University of Oviedo
Not applicable
50
Oviedo
2025-03-15
Active, closed
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT06795048Neovascular Age-related Macular Degeneration (nAMD)
DrugFaricimab
Hoffmann-La Roche
Phase 4
274
Sant Cugat de Valles, Majadahonda, Burjassot, Valencia(España), Madrid, Seville
2025-03-14
Recruiting
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
NCT06571149Ischemic Stroke
DrugsAlteplase·Tenecteplase
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Barcelona
2025-03-14
Active, closed
EucaLimus Post-Market Registry
NCT06621524Coronary Arterioscleroses
OrbusNeich
Observational
251
L'Hospitalet de Llobregat, Barcelona, Córdoba, Lugo, San Cristóbal de La Laguna, Tarragona
2025-03-14
Recruiting
Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke
NCT05930145Stroke, Thrombectomy, Arterial Occlusive Diseases
Fundación EPIC
Not applicable
200
Barakaldo, Oviedo, Valladolid
2025-03-14
Recruiting
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
NCT06833008Advanced Solid Tumor
Ipsen
Phase 1/2
85
Barcelona, Madrid
2025-03-14
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060Heart Failure
AstraZeneca
Phase 3
11,300
A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Sant Joan Despí, Santiago(A Coruña)
2025-03-14
Recruiting
AI-assisted Transcranial Duplex Sonography for Early Detection of Intracerebral Haemorrhage: HYPER-AI-SCAN
NCT07319013Stroke, Intracerebral Hemorrhage, Intracerebral Hemorrhage Basal Ganglia, Intracerebral Haemorrhage
Hospital Universitari Vall d'Hebron Research Institute
Observational
500
Barcelona
2025-03-14
Active, closed
Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis
NCT07028879Multiple Sclerosis
Hospital Clinic of Barcelona
Not applicable
24
Barcelona
2025-03-13
Recruiting
Study to Analyse the Use of a Digital Platform for the Preparation and Follow-up of Patients With Scheduled Outpatients Colonoscopy
NCT06916052Outpatient Colonoscopy
Persei Vivarium
Observational
225
Barcelona
2025-03-13
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
DrugsAbiraterone·Enzalutamide·Docetaxel
Celgene
Phase 3
960
Córdoba, Barcelona, Sabadell, Barakaldo, Santander, Lugo, Madrid, Majadahonda
2025-03-13
Recruiting
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
NCT06869551Juvenile Psoriatic Arthritis
DrugDeucravacitinib
Bristol-Myers Squibb
Phase 3
60
Barcelona, Madrid, Valencia
2025-03-13
Recruiting
Treatment of Lateral Epicondylalgia With Shock Waves
NCT06587412Epicondylitis of the Elbow, Epicondylitis, Lateral
University of Alcala
Not applicable
50
Alcalá de Henares
2025-03-12
Active, closed
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858839Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
3,853
Almería, Castilleja de la Cuesta, Huelva, Sanlúcar de Barrameda, Seville, A Coruña, Pozuelo de Alarcón, Pamplona
2025-03-12
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
NCT06615479Relapsed or Refractory Multiple Myeloma (RRMM)
DrugsBMS-986393·Carfilzomib·Pomalidomide·Daratumumab
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Santiago de Compostela, Palma, Badalona, Pamplona, Granada, Salamanca
2025-03-12
Recruiting
Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography
NCT07638137Angina (Stable), Percutaneous Coronary Intervention (PCI), INOCA (Ischemia With Non Obstructive Coronary Artery Disease), Chronic Coronary Syndrome
Fundacion Investigacion Interhospitalaria Cardiovascular
Observational
246
Leganés, Madrid, Valencia
2025-03-12
Recruiting
Video Classification of Intubation in Spain (VCI) (Pediatrics)
NCT06881576Difficult Intubation
Clinica Universidad de Navarra, Universidad de Navarra
Observational
1,500
Madrid
2025-03-12
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT06792695Metastatic Colorectal Cancer
DrugsFOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)·Volrustomig·Bevacizumab
AstraZeneca
Phase 2
80
Barcelona, Madrid, Málaga, Pamplona, Santander, Valencia
2025-03-12
Active, closed
Blood Flow Restriction in Older Adults
NCT06906523Older Patients
Universidad Católica San Antonio de Murcia
Not applicable
18
Murcia
2025-03-12
Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
NCT06788756Acute Myeloid Leukaemia (AML)
DrugCytarabine
Moleculin Biotech, Inc.
Phase 2/3
312
Barcelona, Oviedo, Madrid, Valencia
2025-03-12
Recruiting
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
NCT06668181Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis
DrugBimekizumab
UCB Biopharma SRL
Phase 3
40
Esplugues de Llobregat, Madrid, Valencia
2025-03-11
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
DrugRimegepant
Pfizer
Phase 3
723
Barcelona, Santander, Chiclana de la Frontera, Madrid, Seville, Valladolid, Zaragoza
2025-03-11
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Sabadell, Las Palmas de Gran Canaria, Madrid, Seville
2025-03-11
Recruiting
CD8 PET Imaging in Metastatic Solid Tumours
NCT06534190Locally Advanced Solid Tumor
DrugsCetrelimab·Nivolumab
University Medical Center Groningen
Phase 2
30
Barcelona
2025-03-11
Not yet open
Evaluating the Feasibility of a Web-App for Pelvic Floor Health in Pregnant Women in the Ferrol Health Area: the WaPRUIN Study
NCT06797323Pregnancy, Pelvic Floor Disorder
Universidad de Oviedo
Observational
212
Ferrol
2025-03-10
Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
NCT06925542SLE (Systemic Lupus), Lupus Erythematosus, Systemic, Lupus Nephritis, Systemic Sclerosis
DrugCTX112
CRISPR Therapeutics
Phase 1
80
Córdoba, Pamplona, Seville
2025-03-10
Recruiting
Evaluation of a Digital School-Based Intervention for the Primary Prevention of Eating Disorders in Pre-Adolescents (PRETA Program)
NCT06792981Eating Disorders in Adolescence, Food Addiction
Servicio Canario de Salud
Not applicable
1,068
Santa Cruz de Tenerife
2025-03-10
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
NCT06671496Psoriatic Arthritis
DrugZasocitinib
Takeda
Phase 3
600
Vitoria-Gasteiz, Santander, Alcobendas, Madrid, Santa Cruz de Tenerife, Seville
2025-03-10
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
A Coruña, Barcelona, Madrid, Salamanca, Valencia
2025-03-10
Recruiting
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
NCT07008365Acute Heart Failure, Congestive Heart Failure, Intraabdominal Hypertension, Cardio-Renal Syndrome
Instituto de Investigación Sanitaria Aragón
Phase 3
168
Zaragoza
2025-03-10
Recruiting
177Lu-DOTATATE for Recurrent Meningioma
NCT06326190Recurrent Meningioma
DrugLutathera
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Barcelona, Madrid
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Barcelona, Zaragoza
2025-03-07
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
NCT06772623Non Small Cell Lung Carcinoma
DrugsBudigalimab·Telisotuzumab Adizutecan·Pemetrexed·Cisplatin
AbbVie
Phase 1/2
252
Santander, Seville, A Coruña, Alicante, Barcelona, Málaga
2025-03-06
Recruiting
Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa
NCT06716814Haemophilia A (Moderate or Severe)
DrugEfanesoctocog alfa
Swedish Orphan Biovitrum
Phase 3
104
A Coruña, Zaragoza
2025-03-06
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Barcelona, Madrid, Valencia
2025-03-06
Active, closed
An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06767462Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca
Observational
160
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Leganés, Madrid, Majadahonda, Salamanca
2025-03-05
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996Mantle Cell Lymphoma, B Cell Lymphoma
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 3
300
Barcelona, Madrid, Majadahonda
2025-03-05
Active, closed
Exer-WAPA Project: Physical Exercise on Women's Affective and Physical HeAlth
NCT07466979Psychological Distress, Anxiety Symptoms, Depression Symptoms
Universidad de Granada
Not applicable
100
Granada
2025-03-04
Recruiting
Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence
NCT06783374Urge Urinary Incontinence, Overactive Bladder (OAB)
Fundación Universidad Católica de Valencia San Vicente Mártir
Not applicable
63
Valencia
2025-03-04
Rows per page Showing 2001–2100 of 5885
Previous 19 20 21 22 23 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-spain?page=21

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,885 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Spain?

3,103 of the 5,885 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 504 have not yet opened recruitment, 2,059 are active but closed to new participants, and 219 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (116) Multiple Myeloma (75) Heart Failure (60) Obesity (56) Non-Small Cell Lung Cancer (46) Carcinoma, Non-Small-Cell Lung (45) Non-small Cell Lung Cancer (45) Colorectal Cancer (44) Prostate Cancer (43) Advanced Solid Tumor (43) Ovarian Cancer (39) Multiple Sclerosis (37) Coronary Artery Disease (37) Advanced Solid Tumors (35) Stroke (35)
→

Browse trials by site location

Barcelona (3233) Madrid (3015) Valencia (1201) Seville (1055) Málaga (741) Pamplona (602) Badalona (557) A Coruña (484) L'Hospitalet de Llobregat (446) Córdoba (436) Santander (402) Santiago de Compostela (384) Salamanca (363) Granada (308) Alicante (275)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.